บริษัทญี่ปุ่นลุยทดสอบยาสกัด “แอนตีบอดี” จากผู้ป่วยหายโควิด ลุ้นใช้รักษาภายในปีนี้

ภาพประกอบ: Takeda Pharmaceutical Co Ltd could start a clinical trial as early as July for a potential treatment of Covid-19 that is based on antibodies from recovered patients’ blood. Photo: Tomohiro Ohsumi/ CNBC

ภาพประกอบ: CoVIg-19 Plasma Alliance’s treatment is based on the plasma of patients who have recovered from COVID-19. Known as hyperimmune immunoglobulins, these drugs are made by purifying antibodies from donated plasma. Photo: Rawpixel

ภาพประกอบ: South Korea: plasma-derived therapies proved effective in reducing mortality during the outbreak of Middle East respiratory syndrome (Mers) in 2009. Photo: AFP

ภาพประกอบ: Medical workers in the Intensive Care Unit for coronavirus patients at St. Marianna Medical University Hospital in Kawasaki, Tokyo. Photo: REUTERS

An employee of an electronics retail store wearing a protective face mask and face shield holds a placard as he calls people to practice social distancing in Tokyo, Japan May 9, 2020. Photo: REUTERS

An elementary school reopens with students wearing face masks, following the COVID-19 outbreak, in Nagasaki, southern Japan. Kyodo/via REUTERS